1st Quarter - Termination

THE LIVESTRONG FOUNDATION for THE LIVESTRONG FOUNDATION

Firm
Client
Income
—
Expenses
$40,000
Expense method
A: Lobbying Disclosure Act definitions
Terminated
Jan 1, 2017

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Congress: Patient Protection and Affordable Care Act (P.L. 111-148), ensuring coverage and access for cancer patients is preserved. NIH: 21st Century Cures Act, requesting timely transfer of funding to the National cancer Institutes. FDA: Reauthorization of the Prescription Drug User Fee Act (PDUFA) as well as new requirements for the FDA as outlined in the 21st Century Cures Act, request to incorporate psychosocial distress screening across the cancer care continuum HHS: CMS-9929-P, Patient Protection and Affordable Care Act; Market Stabilization, provisions related to open/special enrollment, guaranteed issue, actuarial value, and network adequacy.

LobbyistCovered position, as disclosed
CAMERON KRIER Legislative Counsel for former Sen. Kay Bailey Hutchison

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE

Budget/Appropriations BUD

FY 2018 funding for cancer survivorship services President's Budget for FY 2018 and proposed cuts to NIH/NCI.

LobbyistCovered position, as disclosed
CAMERON KRIER Legislative Counsel for former Sen. Kay Bailey Hutchison

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.